Mastic and Reduced Liver Inflammation Fibrosis Score

• Effect of Mastiha supplementation on NAFLD: The MAST4HEALTH Randomised, Controlled Trial.

  • 2021-04-16
  • RCT
  • Molecular nutrition & food research 65(10)
  • • Charalampia Amerikanou
    • Stavroula Kanoni
    • Andriana C Kaliora
    • Angela Barone
    • Mladen Bjelan
    • Giuseppe D'Auria
    • Aristea Gioxari
    • María José Gosalbes
    • Sofia Mouchti
    • Maria G Stathopoulou
    • Beatriz Soriano
    • Stefan Stojanoski
    • Rajarshi Banerjee
    • Maria Halabalaki
    • Eleni V Mikropoulou
    • Aimo Kannt
    • John Lamont
    • Carlos Llorens
    • Fernando Marascio
    • Miriam Marascio
    • Francisco J Roig
    • Ilias Smyrnioudis
    • Iraklis Varlamis
    • Sophie Visvikis-Siest
    • Milan Vukic
    • Natasa Milic
    • Milica Medic-Stojanoska
    • Lucia Cesarini
    • Jonica Campolo
    • Amalia Gastaldelli
    • Panos Deloukas
    • Maria Giovanna Trivella
    • M Pilar Francino
    • George V Dedoussis

  • PubMed: 33629536
  • DOI: 10.1002/mnfr.202001178

  9 Insights on

  • Reduced Liver Inflammation Fibrosis Score

  • High evidence
  • Rigorous Journal
  • Clinical

  after BMI stratification (BMI ≤ 35 kg m⁻² and BMI > 35 kg m⁻²), severely obese patients show an improvement in cT1 and LIF in Mastiha versus Placebo

  Effect

  Beneficial

  Effect size

  Small

  Significant

  Yes